Mountain Pacific Investment Advisers Inc. ID reduced its position in shares of Teleflex Incorporated (NYSE:TFX) by 2.2% during the 3rd quarter, according to the company in its most recent 13F filing with the Securities & Exchange Commission. The institutional investor owned 102,838 shares of the medical technology company’s stock after selling 2,290 shares during the quarter. Teleflex accounts for approximately 2.7% of Mountain Pacific Investment Advisers Inc. ID’s investment portfolio, making the stock its 12th biggest holding. Mountain Pacific Investment Advisers Inc. ID owned approximately 0.23% of Teleflex worth $24,884,000 at the end of the most recent quarter.

Several other hedge funds have also recently bought and sold shares of TFX. Janus Henderson Group PLC boosted its stake in shares of Teleflex by 50,429.2% during the 2nd quarter. Janus Henderson Group PLC now owns 1,816,020 shares of the medical technology company’s stock worth $377,296,000 after acquiring an additional 1,812,426 shares in the last quarter. Koch Industries Inc. boosted its stake in shares of Teleflex by 47,174.3% during the 2nd quarter. Koch Industries Inc. now owns 959,669 shares of the medical technology company’s stock worth $955,000 after acquiring an additional 957,639 shares in the last quarter. Marshall Wace North America L.P. boosted its stake in shares of Teleflex by 137.4% during the 2nd quarter. Marshall Wace North America L.P. now owns 518,462 shares of the medical technology company’s stock worth $107,840,000 after acquiring an additional 300,069 shares in the last quarter. Principal Financial Group Inc. boosted its stake in shares of Teleflex by 93.5% during the 2nd quarter. Principal Financial Group Inc. now owns 610,398 shares of the medical technology company’s stock worth $126,816,000 after acquiring an additional 294,935 shares in the last quarter. Finally, American Century Companies Inc. boosted its stake in shares of Teleflex by 22.8% during the 2nd quarter. American Century Companies Inc. now owns 839,080 shares of the medical technology company’s stock worth $174,327,000 after acquiring an additional 155,863 shares in the last quarter. 89.75% of the stock is currently owned by institutional investors and hedge funds.

TFX has been the topic of several recent analyst reports. Zacks Investment Research raised shares of Teleflex from a “hold” rating to a “buy” rating and set a $261.00 target price on the stock in a research note on Tuesday, September 12th. BidaskClub lowered shares of Teleflex from a “hold” rating to a “sell” rating in a research note on Tuesday, August 8th. Barclays PLC reissued an “overweight” rating and set a $253.00 target price (up from $230.00) on shares of Teleflex in a research note on Tuesday, September 12th. Needham & Company LLC reissued a “buy” rating on shares of Teleflex in a research note on Friday, August 4th. Finally, Jefferies Group LLC reissued a “buy” rating and set a $253.00 target price (up from $230.00) on shares of Teleflex in a research note on Wednesday, August 9th. One analyst has rated the stock with a sell rating, two have issued a hold rating and seven have assigned a buy rating to the company. The stock currently has a consensus rating of “Buy” and an average price target of $260.75.

TRADEMARK VIOLATION WARNING: “Teleflex Incorporated (TFX) Stake Lessened by Mountain Pacific Investment Advisers Inc. ID” was reported by Daily Political and is the sole property of of Daily Political. If you are viewing this report on another site, it was illegally copied and republished in violation of US and international copyright and trademark legislation. The correct version of this report can be viewed at https://www.dailypolitical.com/2017/10/23/teleflex-incorporated-tfx-stake-lessened-by-mountain-pacific-investment-advisers-inc-id.html.

In other Teleflex news, Director Stephen K. M.D. Klasko sold 200 shares of the company’s stock in a transaction dated Tuesday, August 1st. The shares were sold at an average price of $208.41, for a total transaction of $41,682.00. Following the transaction, the director now directly owns 8,080 shares in the company, valued at $1,683,952.80. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is available at this link. Insiders have sold 600 shares of company stock worth $132,408 over the last 90 days. 2.39% of the stock is currently owned by company insiders.

Shares of Teleflex Incorporated (TFX) traded up 0.85% on Monday, reaching $245.13. 31,094 shares of the company were exchanged. The stock has a 50 day moving average of $237.64 and a 200-day moving average of $212.69. The company has a market capitalization of $11.04 billion, a P/E ratio of 46.88 and a beta of 1.07. Teleflex Incorporated has a 52-week low of $136.53 and a 52-week high of $248.68.

Teleflex (NYSE:TFX) last issued its earnings results on Thursday, August 3rd. The medical technology company reported $2.04 earnings per share for the quarter, topping the consensus estimate of $1.91 by $0.13. Teleflex had a net margin of 12.36% and a return on equity of 16.12%. The company had revenue of $528.60 million for the quarter, compared to analyst estimates of $518.98 million. During the same period in the prior year, the business posted $1.89 earnings per share. The firm’s revenue for the quarter was up 11.6% compared to the same quarter last year. On average, analysts predict that Teleflex Incorporated will post $8.29 EPS for the current fiscal year.

About Teleflex

Teleflex Incorporated is a provider of medical technology products. The Company designs, develops, manufactures and supplies single-use medical devices used by hospitals and healthcare providers for diagnostic and therapeutic procedures in critical care and surgical applications. The Company operates through six segments: Vascular North America; Anesthesia North America; Surgical North America; Europe, the Middle East and Africa (EMEA); Asia, and Original Equipment Manufacturer (OEM).

Institutional Ownership by Quarter for Teleflex (NYSE:TFX)

Receive News & Ratings for Teleflex Incorporated Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Teleflex Incorporated and related companies with MarketBeat.com's FREE daily email newsletter.